• PDF / 167,658 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 44 Downloads / 213 Views

DOWNLOAD

REPORT

503/20/0868-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 12 Dec 2020 No. 868

1

Recommend Documents

Ixekizumab in psoriatic arthritis: more QALYs, lower cost in Spain

193 86 166KB

Canagliflozin

190 84 167KB

Canagliflozin/dapagliflozin

168 110 165KB

Quality-Adjusted Life Years (QALYs)

147 95 35MB

Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon a

147 18 654KB

Nephropathy

155 13 72MB

Canagliflozin/empagliflozin

182 79 166KB

Canagliflozin/rosuvastatin interaction

163 11 167KB

Depression care for US prostate cancer patients: more QALYs, lower cost

140 79 163KB

OCT improves cost effectiveness of diabetic macular oedema screening

163 14 182KB

Interleukin 6 in follicular fluid reduces embryo fragmentation and improves the clinical pregnancy rate

163 56 296KB

CPAP therapy reduces oxidative stress in patients with glaucoma and OSAS and improves the visual field

173 38 177KB